In addition, in Alzheimer's disease, silybin-treated APP/PS1 transgenic mice showed higher numbers of newly generated microglia, astrocytes, neurons, and neuronal precursor cells, indicating its positive effects on neuro-regeneration. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.